Moreover, the stigma surrounding obesity disproportionately affects lower-income individuals, who are often blamed for their ...
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...
Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate by mimicking the gut hormone (GLP-1) and making people feel full faster.
By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.
Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice. Now, as the next ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results